nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—Desloratadine—allergic rhinitis	0.0847	0.165	CbGbCtD
Fingolimod—CYP3A4—Flunisolide—allergic rhinitis	0.0539	0.105	CbGbCtD
Fingolimod—CYP3A4—Olopatadine—allergic rhinitis	0.0507	0.0984	CbGbCtD
Fingolimod—CYP2D6—Loratadine—allergic rhinitis	0.0487	0.0945	CbGbCtD
Fingolimod—CYP2D6—Diphenhydramine—allergic rhinitis	0.0487	0.0945	CbGbCtD
Fingolimod—CYP2E1—Dexamethasone—allergic rhinitis	0.0353	0.0686	CbGbCtD
Fingolimod—CYP3A4—Montelukast—allergic rhinitis	0.0309	0.0601	CbGbCtD
Fingolimod—CYP3A4—Loratadine—allergic rhinitis	0.0309	0.0601	CbGbCtD
Fingolimod—CYP3A4—Methylprednisolone—allergic rhinitis	0.0283	0.055	CbGbCtD
Fingolimod—CYP3A4—Triamcinolone—allergic rhinitis	0.0214	0.0417	CbGbCtD
Fingolimod—CYP3A4—Betamethasone—allergic rhinitis	0.0184	0.0357	CbGbCtD
Fingolimod—CYP3A4—Prednisolone—allergic rhinitis	0.0182	0.0353	CbGbCtD
Fingolimod—CYP3A4—Hydrocortisone—allergic rhinitis	0.0172	0.0334	CbGbCtD
Fingolimod—CYP2D6—Dexamethasone—allergic rhinitis	0.0168	0.0327	CbGbCtD
Fingolimod—CYP4F2—respiratory system—allergic rhinitis	0.0115	0.105	CbGeAlD
Fingolimod—CYP3A4—Dexamethasone—allergic rhinitis	0.0107	0.0208	CbGbCtD
Fingolimod—S1PR5—skin of body—allergic rhinitis	0.00979	0.0887	CbGeAlD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.0093	0.0785	CbGpPWpGaD
Fingolimod—S1PR1—respiratory system—allergic rhinitis	0.00902	0.0817	CbGeAlD
Fingolimod—CYP4F2—trachea—allergic rhinitis	0.00853	0.0773	CbGeAlD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.00823	0.0695	CbGpPWpGaD
Fingolimod—S1PR4—lung—allergic rhinitis	0.00778	0.0705	CbGeAlD
Fingolimod—S1PR1—epithelium—allergic rhinitis	0.00754	0.0683	CbGeAlD
Fingolimod—SPHK1—bronchus—allergic rhinitis	0.00735	0.0666	CbGeAlD
Fingolimod—SPHK1—skin of body—allergic rhinitis	0.0071	0.0643	CbGeAlD
Fingolimod—CYP4F12—bronchus—allergic rhinitis	0.00706	0.0639	CbGeAlD
Fingolimod—SPHK1—trachea—allergic rhinitis	0.0066	0.0598	CbGeAlD
Fingolimod—CYP4F12—trachea—allergic rhinitis	0.00634	0.0574	CbGeAlD
Fingolimod—S1PR3—lung—allergic rhinitis	0.00544	0.0492	CbGeAlD
Fingolimod—S1PR1—lung—allergic rhinitis	0.00479	0.0434	CbGeAlD
Fingolimod—SPHK1—lung—allergic rhinitis	0.00474	0.0429	CbGeAlD
Fingolimod—CYP4F12—lung—allergic rhinitis	0.00455	0.0413	CbGeAlD
Fingolimod—S1PR4—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00308	0.026	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00296	0.025	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00296	0.025	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00269	0.0227	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00245	0.0207	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00235	0.0199	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00235	0.0199	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00214	0.0181	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00192	0.0162	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00186	0.0157	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00185	0.0157	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00185	0.0156	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00185	0.0156	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00179	0.0151	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00179	0.0151	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00178	0.0151	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00178	0.0151	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00168	0.0142	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00163	0.0137	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00162	0.0137	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00146	0.0123	CbGpPWpGaD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.00145	0.0122	CbGpPWpGaD
Fingolimod—CYP2E1—respiratory system—allergic rhinitis	0.00145	0.0131	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—CCL11—allergic rhinitis	0.00141	0.0119	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00141	0.0119	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00141	0.0119	CbGpPWpGaD
Fingolimod—SPHK1—Betamethasone—Flunisolide—allergic rhinitis	0.00137	0.147	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Flunisolide—allergic rhinitis	0.00137	0.147	CbGdCrCtD
Fingolimod—S1PR3—GPCR ligand binding—CCL11—allergic rhinitis	0.00136	0.0115	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCL11—allergic rhinitis	0.00136	0.0115	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00135	0.0114	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.0013	0.0109	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.0013	0.0109	CbGpPWpGaD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.00128	0.0108	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00128	0.0108	CbGpPWpGaD
Fingolimod—Visual acuity reduced—Betamethasone—allergic rhinitis	0.00128	0.00517	CcSEcCtD
Fingolimod—Visual acuity reduced—Dexamethasone—allergic rhinitis	0.00128	0.00517	CcSEcCtD
Fingolimod—Mediastinal disorder—Olopatadine—allergic rhinitis	0.00125	0.00507	CcSEcCtD
Fingolimod—Palpitations—Desloratadine—allergic rhinitis	0.00125	0.00506	CcSEcCtD
Fingolimod—Cough—Desloratadine—allergic rhinitis	0.00123	0.005	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CCL11—allergic rhinitis	0.00123	0.0104	CbGpPWpGaD
Fingolimod—Bronchitis—Cetirizine—allergic rhinitis	0.00118	0.00479	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00118	0.00994	CbGpPWpGaD
Fingolimod—Back pain—Olopatadine—allergic rhinitis	0.00117	0.00474	CcSEcCtD
Fingolimod—Bronchitis—Flunisolide—allergic rhinitis	0.00116	0.00471	CcSEcCtD
Fingolimod—Depression—Loratadine—allergic rhinitis	0.00116	0.00471	CcSEcCtD
Fingolimod—Infection—Desloratadine—allergic rhinitis	0.00115	0.00464	CcSEcCtD
Fingolimod—Vision blurred—Olopatadine—allergic rhinitis	0.00114	0.00461	CcSEcCtD
Fingolimod—Nervous system disorder—Desloratadine—allergic rhinitis	0.00113	0.00458	CcSEcCtD
Fingolimod—Vision blurred—Diphenhydramine—allergic rhinitis	0.00112	0.00452	CcSEcCtD
Fingolimod—Vision blurred—Dimenhydrinate—allergic rhinitis	0.00112	0.00452	CcSEcCtD
Fingolimod—Hypotension—Cyproheptadine—allergic rhinitis	0.00111	0.00449	CcSEcCtD
Fingolimod—Pneumonia—Cetirizine—allergic rhinitis	0.0011	0.00447	CcSEcCtD
Fingolimod—Pneumonia—Flunisolide—allergic rhinitis	0.00109	0.00439	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Montelukast—allergic rhinitis	0.00108	0.00435	CcSEcCtD
Fingolimod—Paraesthesia—Cyproheptadine—allergic rhinitis	0.00107	0.00432	CcSEcCtD
Fingolimod—Cough—Olopatadine—allergic rhinitis	0.00106	0.00427	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Montelukast—allergic rhinitis	0.00105	0.00426	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00105	0.00889	CbGpPWpGaD
Fingolimod—Palpitations—Dimenhydrinate—allergic rhinitis	0.00105	0.00423	CcSEcCtD
Fingolimod—Palpitations—Diphenhydramine—allergic rhinitis	0.00105	0.00423	CcSEcCtD
Fingolimod—Influenza—Montelukast—allergic rhinitis	0.00103	0.00418	CcSEcCtD
Fingolimod—Sinusitis—Cetirizine—allergic rhinitis	0.00103	0.00417	CcSEcCtD
Fingolimod—Dyspnoea—Desloratadine—allergic rhinitis	0.00103	0.00417	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—TAC1—allergic rhinitis	0.00103	0.00866	CbGpPWpGaD
Fingolimod—Fatigue—Cyproheptadine—allergic rhinitis	0.00102	0.00415	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Olopatadine—allergic rhinitis	0.00102	0.00414	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00101	0.00855	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00101	0.00855	CbGpPWpGaD
Fingolimod—Sinusitis—Flunisolide—allergic rhinitis	0.00101	0.0041	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.000997	0.00404	CcSEcCtD
Fingolimod—Fatigue—Desloratadine—allergic rhinitis	0.000995	0.00403	CcSEcCtD
Fingolimod—Bronchitis—Montelukast—allergic rhinitis	0.000993	0.00402	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—TAC1—allergic rhinitis	0.000987	0.00834	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—TAC1—allergic rhinitis	0.000987	0.00834	CbGpPWpGaD
Fingolimod—Infection—Olopatadine—allergic rhinitis	0.000981	0.00397	CcSEcCtD
Fingolimod—Nervous system disorder—Olopatadine—allergic rhinitis	0.000968	0.00392	CcSEcCtD
Fingolimod—Skin disorder—Olopatadine—allergic rhinitis	0.000959	0.00388	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000956	0.00807	CbGpPWpGaD
Fingolimod—Pneumonia—Montelukast—allergic rhinitis	0.000926	0.00375	CcSEcCtD
Fingolimod—Alopecia—Loratadine—allergic rhinitis	0.000925	0.00375	CcSEcCtD
Fingolimod—Eye disorder—Cetirizine—allergic rhinitis	0.000921	0.00373	CcSEcCtD
Fingolimod—Infestation—Montelukast—allergic rhinitis	0.00092	0.00373	CcSEcCtD
Fingolimod—Infestation NOS—Montelukast—allergic rhinitis	0.00092	0.00373	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00092	0.00777	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00092	0.00777	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00092	0.00777	CbGpPWpGaD
Fingolimod—Cardiac disorder—Cetirizine—allergic rhinitis	0.000914	0.0037	CcSEcCtD
Fingolimod—Hypotension—Dimenhydrinate—allergic rhinitis	0.000903	0.00365	CcSEcCtD
Fingolimod—Hypotension—Diphenhydramine—allergic rhinitis	0.000903	0.00365	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—TAC1—allergic rhinitis	0.000896	0.00757	CbGpPWpGaD
Fingolimod—Dyspnoea—Olopatadine—allergic rhinitis	0.00088	0.00356	CcSEcCtD
Fingolimod—Alopecia—Cetirizine—allergic rhinitis	0.000871	0.00352	CcSEcCtD
Fingolimod—Paraesthesia—Diphenhydramine—allergic rhinitis	0.000867	0.00351	CcSEcCtD
Fingolimod—Paraesthesia—Dimenhydrinate—allergic rhinitis	0.000867	0.00351	CcSEcCtD
Fingolimod—Sinusitis—Montelukast—allergic rhinitis	0.000863	0.0035	CcSEcCtD
Fingolimod—Mental disorder—Cetirizine—allergic rhinitis	0.000863	0.00349	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.000852	0.00345	CcSEcCtD
Fingolimod—Asthenia—Cyproheptadine—allergic rhinitis	0.000852	0.00345	CcSEcCtD
Fingolimod—Fatigue—Olopatadine—allergic rhinitis	0.000851	0.00345	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000835	0.00705	CbGpPWpGaD
Fingolimod—Fatigue—Diphenhydramine—allergic rhinitis	0.000833	0.00337	CcSEcCtD
Fingolimod—Fatigue—Dimenhydrinate—allergic rhinitis	0.000833	0.00337	CcSEcCtD
Fingolimod—Back pain—Cetirizine—allergic rhinitis	0.00083	0.00336	CcSEcCtD
Fingolimod—Asthenia—Desloratadine—allergic rhinitis	0.000828	0.00335	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000826	0.00697	CbGpPWpGaD
Fingolimod—Pruritus—Desloratadine—allergic rhinitis	0.000817	0.00331	CcSEcCtD
Fingolimod—Back pain—Flunisolide—allergic rhinitis	0.000816	0.0033	CcSEcCtD
Fingolimod—Diarrhoea—Cyproheptadine—allergic rhinitis	0.000813	0.00329	CcSEcCtD
Fingolimod—Connective tissue disorder—Montelukast—allergic rhinitis	0.000812	0.00329	CcSEcCtD
Fingolimod—Vision blurred—Cetirizine—allergic rhinitis	0.000808	0.00327	CcSEcCtD
Fingolimod—Palpitations—Loratadine—allergic rhinitis	0.000805	0.00326	CcSEcCtD
Fingolimod—Cough—Loratadine—allergic rhinitis	0.000795	0.00322	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000795	0.00671	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000795	0.00671	CbGpPWpGaD
Fingolimod—Vision blurred—Flunisolide—allergic rhinitis	0.000795	0.00322	CcSEcCtD
Fingolimod—Diarrhoea—Desloratadine—allergic rhinitis	0.00079	0.0032	CcSEcCtD
Fingolimod—Hypertension—Loratadine—allergic rhinitis	0.000787	0.00319	CcSEcCtD
Fingolimod—Dizziness—Cyproheptadine—allergic rhinitis	0.000785	0.00318	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.000771	0.00312	CcSEcCtD
Fingolimod—CYP2E1—lung—allergic rhinitis	0.000768	0.00696	CbGeAlD
Fingolimod—Cardiac disorder—Montelukast—allergic rhinitis	0.000767	0.0031	CcSEcCtD
Fingolimod—Dizziness—Desloratadine—allergic rhinitis	0.000763	0.00309	CcSEcCtD
Fingolimod—Palpitations—Cetirizine—allergic rhinitis	0.000758	0.00307	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00075	0.00633	CbGpPWpGaD
Fingolimod—Cough—Cetirizine—allergic rhinitis	0.000748	0.00303	CcSEcCtD
Fingolimod—Palpitations—Flunisolide—allergic rhinitis	0.000745	0.00302	CcSEcCtD
Fingolimod—Mediastinal disorder—Montelukast—allergic rhinitis	0.000745	0.00301	CcSEcCtD
Fingolimod—Headache—Cyproheptadine—allergic rhinitis	0.000744	0.00301	CcSEcCtD
Fingolimod—Hypertension—Cetirizine—allergic rhinitis	0.00074	0.003	CcSEcCtD
Fingolimod—Cough—Flunisolide—allergic rhinitis	0.000736	0.00298	CcSEcCtD
Fingolimod—Nervous system disorder—Loratadine—allergic rhinitis	0.00073	0.00295	CcSEcCtD
Fingolimod—Hypertension—Flunisolide—allergic rhinitis	0.000728	0.00295	CcSEcCtD
Fingolimod—Gastroenteritis—Hydrocortisone—allergic rhinitis	0.000728	0.00295	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.000725	0.00294	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCL11—allergic rhinitis	0.000724	0.00612	CbGpPWpGaD
Fingolimod—Mental disorder—Montelukast—allergic rhinitis	0.000724	0.00293	CcSEcCtD
Fingolimod—Headache—Desloratadine—allergic rhinitis	0.000723	0.00293	CcSEcCtD
Fingolimod—Skin disorder—Loratadine—allergic rhinitis	0.000723	0.00293	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000722	0.0061	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000722	0.0061	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000722	0.0061	CbGpPWpGaD
Fingolimod—Eczema—Hydrocortisone—allergic rhinitis	0.000718	0.00291	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000709	0.0764	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Hydrocortisone—allergic rhinitis	0.000709	0.0764	CbGdCrCtD
Fingolimod—Asthenia—Olopatadine—allergic rhinitis	0.000708	0.00287	CcSEcCtD
Fingolimod—Pruritus—Olopatadine—allergic rhinitis	0.000698	0.00283	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—CCL11—allergic rhinitis	0.000697	0.00589	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL11—allergic rhinitis	0.000697	0.00589	CbGpPWpGaD
Fingolimod—Infection—Cetirizine—allergic rhinitis	0.000695	0.00282	CcSEcCtD
Fingolimod—Hypotension—Loratadine—allergic rhinitis	0.000695	0.00281	CcSEcCtD
Fingolimod—Asthenia—Diphenhydramine—allergic rhinitis	0.000693	0.00281	CcSEcCtD
Fingolimod—Asthenia—Dimenhydrinate—allergic rhinitis	0.000693	0.00281	CcSEcCtD
Fingolimod—Nervous system disorder—Cetirizine—allergic rhinitis	0.000686	0.00278	CcSEcCtD
Fingolimod—Infection—Flunisolide—allergic rhinitis	0.000684	0.00277	CcSEcCtD
Fingolimod—Skin disorder—Cetirizine—allergic rhinitis	0.00068	0.00275	CcSEcCtD
Fingolimod—Diarrhoea—Olopatadine—allergic rhinitis	0.000675	0.00273	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000669	0.0721	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Methylprednisolone—allergic rhinitis	0.000669	0.0721	CbGdCrCtD
Fingolimod—Paraesthesia—Loratadine—allergic rhinitis	0.000668	0.0027	CcSEcCtD
Fingolimod—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.000661	0.00268	CcSEcCtD
Fingolimod—Diarrhoea—Diphenhydramine—allergic rhinitis	0.000661	0.00268	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Dexamethasone—allergic rhinitis	0.000658	0.0709	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Betamethasone—allergic rhinitis	0.000658	0.0709	CbGdCrCtD
Fingolimod—S1PR1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000656	0.00554	CbGpPWpGaD
Fingolimod—Hypotension—Cetirizine—allergic rhinitis	0.000654	0.00265	CcSEcCtD
Fingolimod—Dizziness—Olopatadine—allergic rhinitis	0.000653	0.00264	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Triamcinolone—allergic rhinitis	0.000643	0.0693	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Triamcinolone—allergic rhinitis	0.000643	0.0693	CbGdCrCtD
Fingolimod—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000642	0.0026	CcSEcCtD
Fingolimod—Fatigue—Loratadine—allergic rhinitis	0.000641	0.0026	CcSEcCtD
Fingolimod—Dizziness—Dimenhydrinate—allergic rhinitis	0.000639	0.00259	CcSEcCtD
Fingolimod—Dizziness—Diphenhydramine—allergic rhinitis	0.000639	0.00259	CcSEcCtD
Fingolimod—Palpitations—Montelukast—allergic rhinitis	0.000636	0.00257	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCL11—allergic rhinitis	0.000633	0.00535	CbGpPWpGaD
Fingolimod—Paraesthesia—Cetirizine—allergic rhinitis	0.000629	0.00254	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisolone—allergic rhinitis	0.000628	0.00254	CcSEcCtD
Fingolimod—Cough—Montelukast—allergic rhinitis	0.000628	0.00254	CcSEcCtD
Fingolimod—Dyspnoea—Cetirizine—allergic rhinitis	0.000624	0.00253	CcSEcCtD
Fingolimod—Headache—Olopatadine—allergic rhinitis	0.000618	0.0025	CcSEcCtD
Fingolimod—Dyspnoea—Flunisolide—allergic rhinitis	0.000614	0.00248	CcSEcCtD
Fingolimod—Cardiac arrest—Hydrocortisone—allergic rhinitis	0.000613	0.00248	CcSEcCtD
Fingolimod—Eye pain—Betamethasone—allergic rhinitis	0.00061	0.00247	CcSEcCtD
Fingolimod—Eye pain—Dexamethasone—allergic rhinitis	0.00061	0.00247	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000608	0.00246	CcSEcCtD
Fingolimod—Headache—Diphenhydramine—allergic rhinitis	0.000605	0.00245	CcSEcCtD
Fingolimod—Headache—Dimenhydrinate—allergic rhinitis	0.000605	0.00245	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000604	0.00245	CcSEcCtD
Fingolimod—Fatigue—Cetirizine—allergic rhinitis	0.000603	0.00244	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Prednisolone—allergic rhinitis	0.000596	0.0642	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisolone—allergic rhinitis	0.000596	0.0642	CbGdCrCtD
Fingolimod—Fatigue—Flunisolide—allergic rhinitis	0.000593	0.0024	CcSEcCtD
Fingolimod—Infection—Montelukast—allergic rhinitis	0.000583	0.00236	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—TAC1—allergic rhinitis	0.00058	0.00489	CbGpPWpGaD
Fingolimod—Cardiac arrest—Triamcinolone—allergic rhinitis	0.000577	0.00234	CcSEcCtD
Fingolimod—Cardiac arrest—Methylprednisolone—allergic rhinitis	0.000576	0.00233	CcSEcCtD
Fingolimod—Nervous system disorder—Montelukast—allergic rhinitis	0.000576	0.00233	CcSEcCtD
Fingolimod—Skin disorder—Montelukast—allergic rhinitis	0.00057	0.00231	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000569	0.0023	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—PTGDR2—allergic rhinitis	0.000565	0.00477	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TAC1—allergic rhinitis	0.000558	0.00471	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TAC1—allergic rhinitis	0.000558	0.00471	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTGDR2—allergic rhinitis	0.000543	0.00459	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTGDR2—allergic rhinitis	0.000543	0.00459	CbGpPWpGaD
Fingolimod—Migraine—Dexamethasone—allergic rhinitis	0.000542	0.0022	CcSEcCtD
Fingolimod—Migraine—Betamethasone—allergic rhinitis	0.000542	0.0022	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—IL5—allergic rhinitis	0.000539	0.00455	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000534	0.00216	CcSEcCtD
Fingolimod—Asthenia—Loratadine—allergic rhinitis	0.000534	0.00216	CcSEcCtD
Fingolimod—Paraesthesia—Montelukast—allergic rhinitis	0.000527	0.00213	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—TAC1—allergic rhinitis	0.000526	0.00444	CbGpPWpGaD
Fingolimod—Influenza—Triamcinolone—allergic rhinitis	0.000525	0.00212	CcSEcCtD
Fingolimod—Cardiac arrest—Dexamethasone—allergic rhinitis	0.000524	0.00212	CcSEcCtD
Fingolimod—Cardiac arrest—Betamethasone—allergic rhinitis	0.000524	0.00212	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—IL5—allergic rhinitis	0.000519	0.00438	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL5—allergic rhinitis	0.000519	0.00438	CbGpPWpGaD
Fingolimod—Diarrhoea—Loratadine—allergic rhinitis	0.000509	0.00206	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000507	0.00205	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—TAC1—allergic rhinitis	0.000507	0.00428	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TAC1—allergic rhinitis	0.000507	0.00428	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TAC1—allergic rhinitis	0.000507	0.00428	CbGpPWpGaD
Fingolimod—Fatigue—Montelukast—allergic rhinitis	0.000506	0.00205	CcSEcCtD
Fingolimod—Bronchitis—Triamcinolone—allergic rhinitis	0.000505	0.00204	CcSEcCtD
Fingolimod—Weight decreased—Hydrocortisone—allergic rhinitis	0.000504	0.00204	CcSEcCtD
Fingolimod—Asthenia—Cetirizine—allergic rhinitis	0.000502	0.00203	CcSEcCtD
Fingolimod—Infestation—Hydrocortisone—allergic rhinitis	0.000497	0.00201	CcSEcCtD
Fingolimod—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000497	0.00201	CcSEcCtD
Fingolimod—Pruritus—Cetirizine—allergic rhinitis	0.000495	0.002	CcSEcCtD
Fingolimod—Asthenia—Flunisolide—allergic rhinitis	0.000494	0.002	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000494	0.00417	CbGpPWpGaD
Fingolimod—Dizziness—Loratadine—allergic rhinitis	0.000492	0.00199	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—IL5—allergic rhinitis	0.000489	0.00413	CbGpPWpGaD
Fingolimod—Pruritus—Flunisolide—allergic rhinitis	0.000487	0.00197	CcSEcCtD
Fingolimod—Diarrhoea—Cetirizine—allergic rhinitis	0.000479	0.00194	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—IL5—allergic rhinitis	0.000471	0.00398	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL5—allergic rhinitis	0.000471	0.00398	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL5—allergic rhinitis	0.000471	0.00398	CbGpPWpGaD
Fingolimod—Diarrhoea—Flunisolide—allergic rhinitis	0.000471	0.00191	CcSEcCtD
Fingolimod—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000467	0.00189	CcSEcCtD
Fingolimod—Infestation—Methylprednisolone—allergic rhinitis	0.000467	0.00189	CcSEcCtD
Fingolimod—Headache—Loratadine—allergic rhinitis	0.000466	0.00189	CcSEcCtD
Fingolimod—Bradycardia—Prednisolone—allergic rhinitis	0.000465	0.00188	CcSEcCtD
Fingolimod—Dizziness—Cetirizine—allergic rhinitis	0.000463	0.00187	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—TAC1—allergic rhinitis	0.00046	0.00388	CbGpPWpGaD
Fingolimod—Dizziness—Flunisolide—allergic rhinitis	0.000455	0.00184	CcSEcCtD
Fingolimod—Bradycardia—Hydrocortisone—allergic rhinitis	0.000454	0.00184	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000443	0.00374	CbGpPWpGaD
Fingolimod—Headache—Cetirizine—allergic rhinitis	0.000439	0.00178	CcSEcCtD
Fingolimod—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000438	0.00177	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000437	0.00369	CbGpPWpGaD
Fingolimod—Headache—Flunisolide—allergic rhinitis	0.000431	0.00175	CcSEcCtD
Fingolimod—Weight decreased—Dexamethasone—allergic rhinitis	0.000431	0.00174	CcSEcCtD
Fingolimod—Weight decreased—Betamethasone—allergic rhinitis	0.000431	0.00174	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCL11—allergic rhinitis	0.000428	0.00361	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL5—allergic rhinitis	0.000428	0.00361	CbGpPWpGaD
Fingolimod—Bradycardia—Triamcinolone—allergic rhinitis	0.000428	0.00173	CcSEcCtD
Fingolimod—Bradycardia—Methylprednisolone—allergic rhinitis	0.000427	0.00173	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000426	0.0036	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000426	0.0036	CbGpPWpGaD
Fingolimod—Asthenia—Montelukast—allergic rhinitis	0.000421	0.00171	CcSEcCtD
Fingolimod—Eye disorder—Hydrocortisone—allergic rhinitis	0.000417	0.00169	CcSEcCtD
Fingolimod—Pruritus—Montelukast—allergic rhinitis	0.000415	0.00168	CcSEcCtD
Fingolimod—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000412	0.00167	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CCL11—allergic rhinitis	0.000412	0.00348	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL11—allergic rhinitis	0.000412	0.00348	CbGpPWpGaD
Fingolimod—Diarrhoea—Montelukast—allergic rhinitis	0.000402	0.00163	CcSEcCtD
Fingolimod—Eye disorder—Methylprednisolone—allergic rhinitis	0.000392	0.00159	CcSEcCtD
Fingolimod—Mental disorder—Hydrocortisone—allergic rhinitis	0.000391	0.00158	CcSEcCtD
Fingolimod—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000389	0.00157	CcSEcCtD
Fingolimod—Dizziness—Montelukast—allergic rhinitis	0.000388	0.00157	CcSEcCtD
Fingolimod—Bradycardia—Betamethasone—allergic rhinitis	0.000388	0.00157	CcSEcCtD
Fingolimod—Bradycardia—Dexamethasone—allergic rhinitis	0.000388	0.00157	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000387	0.00327	CbGpPWpGaD
Fingolimod—Angiopathy—Methylprednisolone—allergic rhinitis	0.00038	0.00154	CcSEcCtD
Fingolimod—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000378	0.00153	CcSEcCtD
Fingolimod—Vision blurred—Prednisolone—allergic rhinitis	0.000375	0.00152	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CCL11—allergic rhinitis	0.000374	0.00316	CbGpPWpGaD
Fingolimod—Headache—Montelukast—allergic rhinitis	0.000368	0.00149	CcSEcCtD
Fingolimod—Mental disorder—Methylprednisolone—allergic rhinitis	0.000367	0.00149	CcSEcCtD
Fingolimod—Eye disorder—Dexamethasone—allergic rhinitis	0.000356	0.00144	CcSEcCtD
Fingolimod—Eye disorder—Betamethasone—allergic rhinitis	0.000356	0.00144	CcSEcCtD
Fingolimod—Back pain—Triamcinolone—allergic rhinitis	0.000354	0.00143	CcSEcCtD
Fingolimod—Angiopathy—Dexamethasone—allergic rhinitis	0.000346	0.0014	CcSEcCtD
Fingolimod—Angiopathy—Betamethasone—allergic rhinitis	0.000346	0.0014	CcSEcCtD
Fingolimod—Hypertension—Prednisolone—allergic rhinitis	0.000343	0.00139	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000343	0.00289	CbGpPWpGaD
Fingolimod—Alopecia—Dexamethasone—allergic rhinitis	0.000337	0.00136	CcSEcCtD
Fingolimod—Alopecia—Betamethasone—allergic rhinitis	0.000337	0.00136	CcSEcCtD
Fingolimod—Hypertension—Hydrocortisone—allergic rhinitis	0.000335	0.00136	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CCL11—allergic rhinitis	0.000331	0.00279	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000328	0.00133	CcSEcCtD
Fingolimod—Cough—Triamcinolone—allergic rhinitis	0.000319	0.00129	CcSEcCtD
Fingolimod—Hypertension—Triamcinolone—allergic rhinitis	0.000316	0.00128	CcSEcCtD
Fingolimod—Hypertension—Methylprednisolone—allergic rhinitis	0.000315	0.00128	CcSEcCtD
Fingolimod—Infection—Hydrocortisone—allergic rhinitis	0.000315	0.00127	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—TAC1—allergic rhinitis	0.000311	0.00263	CbGpPWpGaD
Fingolimod—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000311	0.00126	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000309	0.00125	CcSEcCtD
Fingolimod—Skin disorder—Hydrocortisone—allergic rhinitis	0.000308	0.00125	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—TAC1—allergic rhinitis	0.000299	0.00253	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TAC1—allergic rhinitis	0.000299	0.00253	CbGpPWpGaD
Fingolimod—Infection—Triamcinolone—allergic rhinitis	0.000297	0.0012	CcSEcCtD
Fingolimod—Hypotension—Hydrocortisone—allergic rhinitis	0.000296	0.0012	CcSEcCtD
Fingolimod—Infection—Methylprednisolone—allergic rhinitis	0.000296	0.0012	CcSEcCtD
Fingolimod—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000292	0.00118	CcSEcCtD
Fingolimod—Paraesthesia—Prednisolone—allergic rhinitis	0.000291	0.00118	CcSEcCtD
Fingolimod—Skin disorder—Methylprednisolone—allergic rhinitis	0.000289	0.00117	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—IL5—allergic rhinitis	0.000289	0.00244	CbGpPWpGaD
Fingolimod—Hypertension—Dexamethasone—allergic rhinitis	0.000286	0.00116	CcSEcCtD
Fingolimod—Hypertension—Betamethasone—allergic rhinitis	0.000286	0.00116	CcSEcCtD
Fingolimod—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000285	0.00115	CcSEcCtD
Fingolimod—Hypotension—Methylprednisolone—allergic rhinitis	0.000278	0.00113	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—IL5—allergic rhinitis	0.000278	0.00235	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL5—allergic rhinitis	0.000278	0.00235	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000274	0.00111	CcSEcCtD
Fingolimod—Fatigue—Hydrocortisone—allergic rhinitis	0.000273	0.00111	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—TAC1—allergic rhinitis	0.000272	0.00229	CbGpPWpGaD
Fingolimod—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000271	0.00229	CbGpPWpGaD
Fingolimod—Infection—Dexamethasone—allergic rhinitis	0.000269	0.00109	CcSEcCtD
Fingolimod—Infection—Betamethasone—allergic rhinitis	0.000269	0.00109	CcSEcCtD
Fingolimod—Paraesthesia—Triamcinolone—allergic rhinitis	0.000268	0.00109	CcSEcCtD
Fingolimod—Paraesthesia—Methylprednisolone—allergic rhinitis	0.000267	0.00108	CcSEcCtD
Fingolimod—Dyspnoea—Triamcinolone—allergic rhinitis	0.000266	0.00108	CcSEcCtD
Fingolimod—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000266	0.00108	CcSEcCtD
Fingolimod—Nervous system disorder—Betamethasone—allergic rhinitis	0.000266	0.00108	CcSEcCtD
Fingolimod—Fatigue—Triamcinolone—allergic rhinitis	0.000257	0.00104	CcSEcCtD
Fingolimod—Fatigue—Methylprednisolone—allergic rhinitis	0.000257	0.00104	CcSEcCtD
Fingolimod—Hypotension—Dexamethasone—allergic rhinitis	0.000253	0.00102	CcSEcCtD
Fingolimod—Hypotension—Betamethasone—allergic rhinitis	0.000253	0.00102	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—IL5—allergic rhinitis	0.000253	0.00213	CbGpPWpGaD
Fingolimod—Paraesthesia—Betamethasone—allergic rhinitis	0.000243	0.000984	CcSEcCtD
Fingolimod—Paraesthesia—Dexamethasone—allergic rhinitis	0.000243	0.000984	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—TAC1—allergic rhinitis	0.000241	0.00203	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000234	0.000947	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000234	0.000947	CcSEcCtD
Fingolimod—Fatigue—Betamethasone—allergic rhinitis	0.000233	0.000945	CcSEcCtD
Fingolimod—Fatigue—Dexamethasone—allergic rhinitis	0.000233	0.000945	CcSEcCtD
Fingolimod—Asthenia—Hydrocortisone—allergic rhinitis	0.000227	0.000921	CcSEcCtD
Fingolimod—Pruritus—Hydrocortisone—allergic rhinitis	0.000224	0.000908	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—IL5—allergic rhinitis	0.000224	0.00189	CbGpPWpGaD
Fingolimod—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000217	0.000878	CcSEcCtD
Fingolimod—Dizziness—Prednisolone—allergic rhinitis	0.000215	0.000869	CcSEcCtD
Fingolimod—Asthenia—Triamcinolone—allergic rhinitis	0.000214	0.000867	CcSEcCtD
Fingolimod—Asthenia—Methylprednisolone—allergic rhinitis	0.000214	0.000865	CcSEcCtD
Fingolimod—Pruritus—Triamcinolone—allergic rhinitis	0.000211	0.000855	CcSEcCtD
Fingolimod—Pruritus—Methylprednisolone—allergic rhinitis	0.000211	0.000853	CcSEcCtD
Fingolimod—Dizziness—Hydrocortisone—allergic rhinitis	0.00021	0.000849	CcSEcCtD
Fingolimod—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000204	0.000825	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—SMAD3—allergic rhinitis	0.000203	0.00172	CbGpPWpGaD
Fingolimod—Headache—Prednisolone—allergic rhinitis	0.000203	0.000823	CcSEcCtD
Fingolimod—Headache—Hydrocortisone—allergic rhinitis	0.000199	0.000804	CcSEcCtD
Fingolimod—Dizziness—Triamcinolone—allergic rhinitis	0.000197	0.000799	CcSEcCtD
Fingolimod—Dizziness—Methylprednisolone—allergic rhinitis	0.000197	0.000797	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—SMAD3—allergic rhinitis	0.000196	0.00165	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SMAD3—allergic rhinitis	0.000196	0.00165	CbGpPWpGaD
Fingolimod—Asthenia—Dexamethasone—allergic rhinitis	0.000194	0.000787	CcSEcCtD
Fingolimod—Asthenia—Betamethasone—allergic rhinitis	0.000194	0.000787	CcSEcCtD
Fingolimod—Pruritus—Dexamethasone—allergic rhinitis	0.000192	0.000776	CcSEcCtD
Fingolimod—Pruritus—Betamethasone—allergic rhinitis	0.000192	0.000776	CcSEcCtD
Fingolimod—Headache—Triamcinolone—allergic rhinitis	0.000187	0.000757	CcSEcCtD
Fingolimod—Headache—Methylprednisolone—allergic rhinitis	0.000187	0.000755	CcSEcCtD
Fingolimod—Diarrhoea—Betamethasone—allergic rhinitis	0.000185	0.00075	CcSEcCtD
Fingolimod—Diarrhoea—Dexamethasone—allergic rhinitis	0.000185	0.00075	CcSEcCtD
Fingolimod—Dizziness—Dexamethasone—allergic rhinitis	0.000179	0.000725	CcSEcCtD
Fingolimod—Dizziness—Betamethasone—allergic rhinitis	0.000179	0.000725	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—SMAD3—allergic rhinitis	0.000178	0.0015	CbGpPWpGaD
Fingolimod—Headache—Betamethasone—allergic rhinitis	0.00017	0.000687	CcSEcCtD
Fingolimod—Headache—Dexamethasone—allergic rhinitis	0.00017	0.000687	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—SMAD3—allergic rhinitis	0.000157	0.00133	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NFKB1—allergic rhinitis	0.000103	0.000873	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NFKB1—allergic rhinitis	9.95e-05	0.00084	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NFKB1—allergic rhinitis	9.95e-05	0.00084	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFKB1—allergic rhinitis	9.04e-05	0.000763	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—allergic rhinitis	8.61e-05	0.000727	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—allergic rhinitis	8.29e-05	0.0007	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—allergic rhinitis	8.29e-05	0.0007	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKB1—allergic rhinitis	8e-05	0.000675	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—allergic rhinitis	7.53e-05	0.000636	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—allergic rhinitis	6.66e-05	0.000563	CbGpPWpGaD
